FH

Fred Hofmann

MK Merz Pharma Gmbh & Co. Kgaa: 11 patents #3 of 114Top 3%
UN Unknown: 3 patents #7,366 of 83,584Top 9%
📍 Potsdam, DE: #10 of 373 inventorsTop 3%
Overall (All Time): #402,506 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
11952601 Recombinant botulinum toxin with increased duration of effect Marcel JURK, Manuela López De La Paz, Daniel Scheps, Jürgen Frevert 2024-04-09
11357821 Recombinant clostridial neurotoxins with increased duration of effect Juergen Frevert, Michael Schmidt, Manuela López De La Paz, Daniel Scheps 2022-06-14
11155802 Recombinant botulinum neurotoxins with increased duration of effect Jürgen Frevert, Marcel JURK, Manuela López De La Paz, Daniel Scheps 2021-10-26
11078472 Recombinant clostridial neurotoxins with increased duration of effect Marcel JURK, Manuela López De La Paz, Daniel Scheps, Jürgen Frevert 2021-08-03
10603353 Recombinant clostridial neurotoxins with increased duration of effect Jürgen Frevert, Michael Schmidt, Manuela López De La Paz, Daniel Scheps 2020-03-31
9975929 Recombinant clostridial neurotoxins with increased duration of effect Jürgen Frevert, Michael Schmidt 2018-05-22
9827298 Neurotoxins exhibiting shortened biological activity Jürgen Frevert 2017-11-28
9809809 Neurotoxins exhibiting shortened biological activity Michael Schmidt, Jürgen Frevert, Gerhard Groer 2017-11-07
9511114 Neurotoxins exhibiting shortened biological activity Jürgen Frevert 2016-12-06
9193771 Neurotoxins exhibiting shortened biological activity Jürgen Frevert 2015-11-24
8747841 Polypeptides and use thereof for treatment of traumatic or degenerative neuronal injury Gudrun Ahnert-Hilger, Gisela Groβe, Ingo Just, Markus Höltje, Stefanie Hülsenbeck 2014-06-10
8586329 Neurotoxins exhibiting shortened biological activity Jürgen Frevert 2013-11-19